Literature DB >> 21252486

Impact of hypotension and low cerebral perfusion pressure on outcomes in children treated with hypothermia therapy following severe traumatic brain injury: a post hoc analysis of the Hypothermia Pediatric Head Injury Trial.

James S Hutchison1, Helena Frndova, Tsz-Yan M Lo, Anne-Marie Guerguerian.   

Abstract

Hypotension and low cerebral perfusion pressure are known to be associated with unfavorable outcome in children and adults with traumatic brain injury. Using the database from a previously published, randomized controlled trial of 24 h of hypothermia therapy in children with severe traumatic brain injury, we compared the number of patients with hypotension or low cerebral perfusion pressure between the hypothermia therapy and normothermia groups. We also determined the association between these physiologic insults and unfavorable outcome using regression analysis. There were more patients with episodes of hypotension or low cerebral perfusion pressure in the hypothermia therapy group than in the normothermia group. These physiologic insults were associated with unfavorable outcome in both intervention groups. Hypotension and low cerebral perfusion pressure should be anticipated and prevented in future trials of hypothermia therapy in patients with traumatic brain injury.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21252486     DOI: 10.1159/000323260

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  17 in total

Review 1.  Pediatric neurocritical care.

Authors:  Sarah Murphy
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Brain metabolism and severe pediatric traumatic brain injury.

Authors:  Heidi Griffiths; Manu S Goyal; Jose A Pineda
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

Review 3.  A State-of-the-Science Overview of Randomized Controlled Trials Evaluating Acute Management of Moderate-to-Severe Traumatic Brain Injury.

Authors:  Peter Bragge; Anneliese Synnot; Andrew I Maas; David K Menon; D James Cooper; Jeffrey V Rosenfeld; Russell L Gruen
Journal:  J Neurotrauma       Date:  2016-03-18       Impact factor: 5.269

Review 4.  Management of the Pediatric Neurocritical Care Patient.

Authors:  Christopher M Horvat; Haifa Mtaweh; Michael J Bell
Journal:  Semin Neurol       Date:  2016-12-01       Impact factor: 3.420

Review 5.  Quo vadis 2010? - carpe diem: challenges and opportunities in pediatric traumatic brain injury.

Authors:  Patrick M Kochanek; Michael J Bell; Hülya Bayır
Journal:  Dev Neurosci       Date:  2011-01-21       Impact factor: 2.984

6.  Age-specific cerebral perfusion pressure thresholds and survival in children and adolescents with severe traumatic brain injury*.

Authors:  Baxter B Allen; Ya-Lin Chiu; Linda M Gerber; Jamshid Ghajar; Jeffrey P Greenfield
Journal:  Pediatr Crit Care Med       Date:  2014-01       Impact factor: 3.624

7.  Proteomic Profiling Reveals Adaptive Responses to Surgical Myocardial Ischemia-Reperfusion in Hibernating Arctic Ground Squirrels Compared to Rats.

Authors:  Quintin J Quinones; Zhiquan Zhang; Qing Ma; Michael P Smith; Erik Soderblom; M Arthur Moseley; James Bain; Christopher B Newgard; Michael J Muehlbauer; Matthew Hirschey; Kelly L Drew; Brian M Barnes; Mihai V Podgoreanu
Journal:  Anesthesiology       Date:  2016-06       Impact factor: 7.892

8.  Is therapeutic hypothermia beneficial for pediatric patients with traumatic brain injury? A meta-analysis.

Authors:  Chenkai Ma; Xiaoguang He; Lin Wang; Baocheng Wang; Qifeng Li; Feng Jiang; Jie Ma
Journal:  Childs Nerv Syst       Date:  2013-03-16       Impact factor: 1.475

Review 9.  Advances in neurocritical care.

Authors:  Soonu Udani
Journal:  Indian J Pediatr       Date:  2014-10-14       Impact factor: 1.967

Review 10.  Therapeutic Hypothermia in Children and Adults with Severe Traumatic Brain Injury.

Authors:  Anna Sandestig; Bertil Romner; Per-Olof Grände
Journal:  Ther Hypothermia Temp Manag       Date:  2014-03-01       Impact factor: 1.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.